A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate

Susana Lousada-Dietrich, Prajakta Jogdand, Søren Jepsen, Vera V. Pinto, Sisse B. Ditlev, Michael Christiansen, Severin Olesen Larsen, Christopher B. Fox, Vanitha S. Raman, Randall F. Howard,

Vaccine · 2011 · 67 citations · 46 references

Concepts

References

46